PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 9.34

Change

-0.45 (-4.60)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-0.18 (-0.51%)

USD 11.31B
QLD ProShares Ultra QQQ

+0.39 (+0.38%)

USD 7.34B
FNGU MicroSectors FANG+ Index 3X Le..

+7.97 (+1.76%)

USD 5.64B
SSO ProShares Ultra S&P500

-0.29 (-0.31%)

USD 5.41B
UPRO ProShares UltraPro S&P500

-0.43 (-0.48%)

USD 4.11B
TECL Direxion Daily Technology Bull..

+1.39 (+1.50%)

USD 3.52B
YINN Direxion Daily FTSE China Bull..

-1.43 (-4.04%)

USD 2.28B
USD ProShares Ultra Semiconductors

+5.84 (+4.30%)

USD 1.30B
LABU Direxion Daily S&P Biotech Bul..

-6.53 (-4.98%)

USD 0.99B
DPST Direxion Daily Regional Banks ..

-10.24 (-8.93%)

USD 0.85B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1,707.74% 94% A 98% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 1,707.74% 94% A 98% N/A
Trailing 12 Months  
Capital Gain 2,533.46% 94% A 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,533.46% 94% A 99% N/A
Trailing 5 Years  
Capital Gain 867.54% 91% A- 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 867.54% 91% A- 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 16.38% 40% F 79% B-
Dividend Return 16.87% 39% F 77% C+
Total Return 0.49% 38% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 224.07% 16% F 4% F
Risk Adjusted Return 7.53% 19% F 28% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.